Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction

• Status: Completed
• Trial end date: 2020-05-20
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligament reconstruction: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Henry Ford Health System
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Celecoxib; Diazepam; Gabapentin; Hydrocodone; Ketorolac; Ketorolac Tromethamine; Oxycodone

Criteria

Eligibility Criteria:

Inclusion Criteria:

• All adult patients over age 18 and scheduled for a primary or revision anterior cruciate ligament reconstruction

Exclusion Criteria:

• Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact anterior cruciate ligament reconstruction